MDGL
Madrigal Pharmaceuticals, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +8.3% ·
share flow +5.9% ·
net new positions +7.7%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 123 | +1 | 10.48M | $5.62B | +9 | −7 |
| Q1 2026 | 124 | +7 | 12.07M | $6.32B | +9 | −3 |
| Q4 2025 | 116 | 0 | 12.47M | $7.26B | +1 | — |
| Q3 2025 | 19 | +1 | 6.80M | $3.12B | +1 | −1 |
| Q2 2025 | 16 | 0 | 6.45M | $1.95B | — | — |
| Q1 2025 | 13 | +1 | 2.28M | $753.61M | +1 | — |
| Q4 2024 | 12 | +2 | 2.15M | $662.73M | +2 | — |
| Q3 2024 | 9 | +1 | 1.41M | $299.66M | +3 | −2 |
| Q2 2024 | 8 | — | 1.43M | $401.79M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 758.51K | -2.9% | $251.24M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 542.63K | -7.8% | $179.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 542.63K | -7.8% | $179.74M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 420.88K | +2.5% | $139.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 420.88K | +2.5% | $139.44M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Adage Capital Partners ✦ | 191.61K | +860.0% | $63.47M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 99.01K | +315.2% | $32.79M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 94.00K | -18.3% | $31.13M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 9 | Renaissance Technologies ✦ | 85.09K | -47.1% | $28.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Point72 Asset Management ✦ | 65.86K | New | $21.81M | 0.1% | New | 1 | SEC ↗ |
| 11 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 7.63K | -6.7% | $2.53M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 3.77K | -31.2% | $1.25M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | Marshall Wace ✦ | 2.80K | -84.0% | $927,444 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 20 | Millennium Management ✦ | 2.51K | +90.8% | $830,394 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 801 | -94.6% | $265,315 | 0.0% | ▼ Trim | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $21.81M | 0.1% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 374 holders, 23.71M shares, $12.08B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 664 sh · $341,940
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology